Insight Molecular Diagnostics Inc. IMDX
NASDAQ · United States · Health Technology
$3.44-0.03 (-0.86%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | -0.31 | -0.25 | -22.1% | $239.00K | -32.2% | -8.3%$4.83→$4.43 |
| Q4 2025 | 2026-03-26 | -0.72 | -0.24 | -200.0% | — | — | -14.0%$4.14→$3.56 |
| Q2 2025 | 2025-08-11 | -0.30 | -0.24 | -25.0% | — | — | — |
| Q4 2024 | 2025-03-24 | -1.93 | -0.40 | -382.5% | — | — | — |
| Q1 2024 | 2024-05-15 | -0.68 | -0.57 | -19.3% | — | — | — |
| Q4 2023 | 2024-04-12 | -2.07 | -0.99 | -109.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.